By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Menarini Group 

Via Sette Santi, 1

Florence    50131  Italy
Phone: 0039-055-56801 Fax: 0039-055-582771



Company News
Selvita And Menarini Group Announce Global License Agreement For Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24 3/28/2017 11:16:28 AM
Melinta And Menarini Group Enter Into Commercial And Co-Development Agreement For Delafloxacin In 68 Countries 3/2/2017 9:41:40 AM
Menarini Group And MSD Extends Global Partnership To The Asia-Pacific Region 6/9/2016 8:39:22 AM
Moberg Pharma AB (Formerly known as Moberg Derma) And Menarini Group Extend Distribution Agreement For Kerasal Nail To South East Asia 2/14/2014 8:41:46 AM
Oxford BioTherapeutics And Menarini Group Progress Enhanced Antibody For Acute Myeloid Leukemia As First Clinical Development Candidate In $1 Billion Oncology Investment Alliance 12/9/2013 7:57:38 AM
Italian Pharma Giant Menarini Group Eyes India Brands 11/27/2013 7:24:05 AM
Furiex Pharmaceuticals, Inc. (FURX) Announces Priligy® Launch in the United Kingdom by Menarini Group 11/1/2013 10:59:05 AM
The Menarini Group Acquires Silicon Biosystems S.p.A. 9/12/2013 9:56:46 AM
Menarini Group's Glucose Testing Strips Recalled Over False Reading Worry 8/16/2013 8:25:56 AM
Moberg Pharma AB (Formerly known as Moberg Derma) and Menarini Group Extend Distribution Agreement for Kerasal Nail to China 7/22/2013 9:28:48 AM